| Expression pattern: |
UP |
| Associated gene: |
TPBG, AGO2 |
| Associated microRNA: |
miR-653-5p |
| Biological function: |
promotes proliferation, migration, invasion, EMT, angiogenesis, tumor growth and metastasis in breast cancer |
| Molecular mechanism: |
Exosomal circTBPL1 from CAFs is transferred to breast cancer cells and functions as a ceRNA by sponging miR-653-5p, thereby relieving miR-653-5p-mediated repression of TPBG. |
| Biological pathway or process: |
proliferation (promotes); migration (promotes); invasion (promotes); metastasis (promotes); EMT (promotes); angiogenesis (promotes); ceRNA regulation (promotes) |
| Detected method: |
Q
S
|
| Validation methods: |
RNA-seq; RT-qPCR; Back-Splice Junction PCR / divergent primers PCR; RNase R Treatment; Sanger Sequencing; Actinomycin D / DRB Stability Assay; FISH / smFISH; Nuclear-Cytoplasmic Fractionation; ISH (In Situ Hybridization); RIP (RNA Immunoprecipitation); Luciferase Reporter Assay; Transfection; MTT; Colony Formation Assay; EdU Staining; Transwell Assay; Wound Healing Assay; Tube Formation Assay; Western Blot; In Vivo Animal Model; H&E Staining; IHC (Immunohistochemistry); Bioinformatics Analysis; Clinical Sample Validation |
| Clinical significance: |
potential biomarker and novel therapeutic target for breast cancer |
| Description: |
circTBPL1 (hsa_circ_0077892) is enriched and upregulated in CAF-derived exosomes and can be transferred to breast cancer cells. It promotes malignant phenotypes (proliferation, migration/invasion, EMT, angiogenesis, tumor growth and metastasis) mainly by sponging miR-653-5p to derepress TPBG. |
| Confidence score: |
0.872 |